Ryan Bond
Corporate Officer/Principal bij ACLARION, INC.
Vermogen: 411 $ op 31-03-2024
Profiel
Ryan Bond is currently the Chief Strategy Officer at Aclarion, Inc. He previously worked as the Director-Healthcare Solutions at NuVasive, Inc. from 2014 to 2018.
Mr. Bond completed his undergraduate degree at The Ohio University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ACLARION, INC.
0.02% | 30-09-2023 | 1 250 ( 0.02% ) | 411 $ | 31-03-2024 |
Actieve functies van Ryan Bond
| Bedrijven | Functie | Begin |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15-09-2021 |
Eerdere bekende functies van Ryan Bond
| Bedrijven | Functie | Einde |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01-09-2018 |
Opleiding van Ryan Bond
| The Ohio University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACLARION, INC. | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
